These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 25644061

  • 1. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD.
    Mol Cancer; 2015 Feb 03; 14():24. PubMed ID: 25644061
    [Abstract] [Full Text] [Related]

  • 2. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.
    Kang M, Li Y, Liu W, Wang R, Tang A, Hao H, Liu Z, Ou H.
    Int J Mol Med; 2013 Jul 03; 32(1):51-8. PubMed ID: 23677061
    [Abstract] [Full Text] [Related]

  • 3. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
    Lin C, Huang F, Li QZ, Zhang YJ.
    Int J Clin Exp Pathol; 2014 Jul 03; 7(10):6543-50. PubMed ID: 25400732
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
    Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG, Zeng ZY, Cheng HZ.
    Mol Cancer; 2012 Aug 06; 11():51. PubMed ID: 22867052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R.
    BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
    Li W, Zheng J, Deng J, You Y, Wu H, Li N, Lu J, Zhou Y.
    Gastroenterology; 2014 Jun 31; 146(7):1714-26.e5. PubMed ID: 24631494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.
    J Hepatol; 2014 Mar 31; 60(3):590-8. PubMed ID: 24211739
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M, He XY, Zhang ZM, Li S, Ren LH, Cao RS, Feng YD, Ji YL, Zhao Y, Shi RH.
    World J Gastroenterol; 2015 Mar 21; 21(11):3245-55. PubMed ID: 25805931
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
    Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, Zhang W, Xu RH.
    Oncotarget; 2015 May 10; 6(13):10868-79. PubMed ID: 25869101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.
    J Hematol Oncol; 2016 Jan 06; 9():1. PubMed ID: 26733151
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
    Song QC, Shi ZB, Zhang YT, Ji L, Wang KZ, Duan DP, Dang XQ.
    Oncol Rep; 2014 Mar 06; 31(3):1263-70. PubMed ID: 24452597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J.
    Oncotarget; 2015 Nov 10; 6(35):37335-48. PubMed ID: 26484567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.